| Trial ID: | L0614 |
| Source ID: | IRCT2015012520781N1
|
| Associated Drug: |
Silymarin
|
| Title: |
Evaluation of the effect of silimarin in children with nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: In the case group Silimarin capsule manufactured by Sabz Daroo company with dose of 140 mg three times a day is used for 3 months. Intervention 2: In the control group placebo capsule filled with starch, made by the researcher is used t
|
| Outcome Measures: |
AST. Timepoint: Before and after the treatment. Method of measurement: mg/dL.;ALT. Timepoint: Before and after the treatment. Method of measurement: mg/dL.;Fatty liver disease stage. Timepoint: Before and after the treatment. Method of measurement: Ultrasonography.;TG. Timepoint: Before and after the treatment. Method of measurement: mg/dL.;HDL. Timepoint: Before and after the treatment. Method of measurement: mg/dL.;LDL. Timepoint: Before and after the treatment. Method of measurement: mg/dL.nan
|
| Sponsor/Collaborators: |
Qom University of Medical Sciences
|
| Gender: |
All
|
| Age: |
5 years16 years
|
| Phases: |
Not applicable
|
| Enrollment: |
40
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Crossover, Purpose: Treatment.
|
| Start Date: |
04/04/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/18376
|
